ENTITY
GNI Group

GNI Group (2160 JP)

12
Analysis
Health Care • Japan
GNI Group Ltd. develops therapeutic pharmaceutical products utilizing Genome analysis. The Company targets diseases indigenous to Asian countries. GNI controls the whole process of drug discovery by conducting clinical trials, research and development, and marketing. The Company owns global subsidiaries in China and the US.
more
bullish•Mercari
•28 Nov 2021 18:56

TOPIX Inclusions: Who Is READY? 4.0

In this insight, we take a look at potential pre-event candidates who could move to the First Section of the Tokyo Stock Exchange in the next few...

Share
bullish•GNI Group
•18 Oct 2018 14:10

Investment Thesis and Valuation

Key Drivers / Concerns Etuary’s inclusion in China insurance reimbursement program Stable income from recently acquired medical device...

x